BACKGROUND: The purpose of this study was to develop an automated surveillance system, using pressure-based hemodynamic factors that would detect which patients were making the transition from compensated to decompensated heart failure before they developed worsening symptoms and required acute medical care. METHODS AND RESULTS: Intracardiac pressures in 274 patients with heart failure were measured using an implantable hemodynamic monitor (IHM) and were analyzed in a retrospective manner. An automated pressure change detection (PCD) algorithm was developed using the cumulative sum method. The performance characteristics of the PCD algorithm were defined in all patients who developed a heart failure-related event (HFRE); patients without HFRE served as controls. Optimal PCD threshold values were chosen using a receiver operator curve analysis. Each of the pressures measured with the IHM were evaluated using the PCD analysis. All had sensitivities ≥80% and false-positive rates <4.7/patient-year; however, estimated pulmonary artery diastolic pressure (ePAD) had the best performance. An ePAD based on the optimized PCD threshold of 6.0 yielded a sensitivity of 83% and a false-positive rate of 4.1/patient-year for detecting patients making the transition from compensated to decompensated heart failure. These performance characteristics were not significantly different for patients with an ejection fraction > vs. <50%, estimated glomerular filtration rate > vs. <60 mL/min/1.73 m(2), or age > vs. <60 years. CONCLUSIONS: The automated PCD algorithm had high sensitivity and acceptable false-positive rates in detecting the development of decompensated heart failure before the patient developed worsening symptoms and required acute medical care. These data support the development of a prospective study to examine the utility of adding an automated PCD algorithm to IHM-based management strategies to prevent decompensated heart failure.
RCT Entities:
BACKGROUND: The purpose of this study was to develop an automated surveillance system, using pressure-based hemodynamic factors that would detect which patients were making the transition from compensated to decompensated heart failure before they developed worsening symptoms and required acute medical care. METHODS AND RESULTS: Intracardiac pressures in 274 patients with heart failure were measured using an implantable hemodynamic monitor (IHM) and were analyzed in a retrospective manner. An automated pressure change detection (PCD) algorithm was developed using the cumulative sum method. The performance characteristics of the PCD algorithm were defined in all patients who developed a heart failure-related event (HFRE); patients without HFRE served as controls. Optimal PCD threshold values were chosen using a receiver operator curve analysis. Each of the pressures measured with the IHM were evaluated using the PCD analysis. All had sensitivities ≥80% and false-positive rates <4.7/patient-year; however, estimated pulmonary artery diastolic pressure (ePAD) had the best performance. An ePAD based on the optimized PCD threshold of 6.0 yielded a sensitivity of 83% and a false-positive rate of 4.1/patient-year for detecting patients making the transition from compensated to decompensated heart failure. These performance characteristics were not significantly different for patients with an ejection fraction > vs. <50%, estimated glomerular filtration rate > vs. <60 mL/min/1.73 m(2), or age > vs. <60 years. CONCLUSIONS: The automated PCD algorithm had high sensitivity and acceptable false-positive rates in detecting the development of decompensated heart failure before the patient developed worsening symptoms and required acute medical care. These data support the development of a prospective study to examine the utility of adding an automated PCD algorithm to IHM-based management strategies to prevent decompensated heart failure.
Authors: A L Pop-Moldovan; N-M Trofenciuc; D A Dărăbanţiu; C Precup; H Branea; R Christodorescu; M Puşchiţă Journal: Cancer Gene Ther Date: 2017-03-03 Impact factor: 5.987
Authors: Jacob Abraham; Rupinder Bharmi; Orvar Jonsson; Guilherme H Oliveira; Andre Artis; Ali Valika; Robert Capodilupo; Philip B Adamson; Gregory Roberts; Nirav Dalal; Akshay S Desai; Raymond L Benza Journal: JAMA Cardiol Date: 2019-06-01 Impact factor: 14.676
Authors: Illapha Cuba Gyllensten; Alberto G Bonomi; Kevin M Goode; Harald Reiter; Joerg Habetha; Oliver Amft; John Gf Cleland Journal: JMIR Med Inform Date: 2016-02-18
Authors: Illapha Cuba Gyllensten; Amanda Crundall-Goode; Ronald M Aarts; Kevin M Goode Journal: BMC Med Inform Decis Mak Date: 2017-01-17 Impact factor: 2.796
Authors: Niraj Varma; Robert C Bourge; Lynne Warner Stevenson; Maria Rosa Costanzo; David Shavelle; Philip B Adamson; Greg Ginn; John Henderson; William T Abraham Journal: J Am Heart Assoc Date: 2021-02-25 Impact factor: 5.501